Therefore, regnase-1 is regarded as a crucial posttranscriptional regulator for the pro-fibrotic function of ILC2s in mice and humans, and its regulatory mechanism for Egr1 and ICOS may provide novel therapeutic strategies for idiopathic pulmonary fibrosis. The gene discussed is ICOS; the disease is pulmonary fibrosis.